Editas Medicine, Inc

(NASDAQ:EDIT)

Latest On Editas Medicine, Inc (EDIT):

Date/Time Type Description Signal Details
2023-05-18 19:53 ESTNewsEditas Medicine strengthens board of directors with appointment of new chair and new directorN/A
2023-05-17 02:54 ESTNewsEditas Medicine, Inc. (EDIT) RBC Capital Markets Global Healthcare Conference 2023 TranscriptN/A
2023-05-17 02:54 ESTNewsEditas Medicine appoints Erick Lucera as CFO, Michelle Robertson steps downN/A
2023-05-14 04:40 ESTNewsEditas Medicine, Inc. (EDIT) Bank of America Global Healthcare Conference Call TranscriptN/A
2023-05-06 02:18 ESTNewsEditas Medicine, Inc. (EDIT) Q1 2023 Earnings Call TranscriptN/A
2023-05-06 02:18 ESTNewsEditas Medicine: Pioneering Gene-Editing Solutions For Inherited Blood Disorders And BeyondN/A
2023-05-05 13:29 ESTNewsEditas Medicine GAAP EPS of -$0.71 beats by $0.08N/A
2023-05-05 00:35 ESTNewsEditas Medicine Q1 2023 Earnings PreviewN/A
2023-04-27 18:11 ESTNewsEditas sickle cell candidate granted FDA Orphan Drug designationN/A
2023-04-13 20:11 ESTNewsHot Stocks: PGR drops on earnings; CNSL rises on buyout offer; MRK higher on analyst upgrade; EDIT gains; HOG slidesN/A
2023-04-13 20:11 ESTNewsGene editing stocks rally as Wall Street turns bullishN/A
2023-02-24 03:35 ESTNewsEditas: The Potential Of Gene Editing Technology And The Risks Of A Lackluster PipelineN/A
2023-02-23 01:21 ESTNewsEditas rises on Q4 revenue beat, gene-editing therapy data for sickle cell disease by mid-yearN/A
2023-02-23 01:21 ESTNewsEditas Medicine, Inc. (EDIT) Q4 2022 Earnings Call TranscriptN/A
2023-02-22 12:28 ESTNewsEditas Medicine GAAP EPS of -$0.88 misses by $0.08, revenue of $6.54M beats by $2.78MN/A
2023-02-21 23:52 ESTNewsEditas Medicine Q4 2022 Earnings PreviewN/A
2023-02-01 16:15 ESTNewsEditas, Beam win bullish views as Cantor launches gene editing coverageN/A
2023-01-19 18:17 ESTNewsEditas to sell natural killer cell programs to ShorelineN/A
2023-01-11 22:12 ESTNewsEditas Medicine, Inc. (EDIT) Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)N/A
2023-01-09 15:48 ESTNewsEditas cuts 20% staff in portfolio overhaulN/A
2022-12-06 18:46 ESTNewsEditas adds 12% after initial data for sickle cell disease candidateN/A
2022-12-06 18:46 ESTNewsEditas Medicine, Inc. (EDIT) EDIT-301 Clinical Update 2022 - (Transcript)N/A
2022-12-06 18:45 ESTNewsEDIT-301 Clinical UpdateN/A
2022-12-06 18:45 ESTNewsEditas Medicine: 3 Positives To Cling To In 2023 (And Why They May Not Be So Positive)N/A
2022-11-18 13:41 ESTNewsEditas Medicine dropped to neutral at Credit Suisse following EDIT-101 trial dataN/A
2022-11-17 20:34 ESTNewsEditas pausing enrollment of blindness drug trial to find partner; shares down 15%N/A
2022-11-04 19:09 ESTNewsEditas Medicine: Q3 Update And 2 Clinical Catalysts To WatchN/A
2022-11-02 16:42 ESTNewsEditas Medicine GAAP EPS of -$0.81 beats by $0.07N/A
2022-11-02 16:41 ESTNewsEditas Medicine, Inc. (EDIT) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 16:41 ESTNewsEditas Medicine rises 7% on Q3 earnings beatN/A
2022-11-02 01:05 ESTNewsEditas Medicine Q3 2022 Earnings PreviewN/A
2022-10-18 18:19 ESTNewsEditas Medicine gains on report of potential sale of pre-clinical cancer pipelineN/A
2022-09-30 01:23 ESTNewsEditas Medicine started at neutral at BofA due to competition in gene editing programsN/A
2022-09-12 17:06 ESTNewsEditas Medicine, Inc. (EDIT) Management Presents at Morgan Stanley 20th Annual Global Healthcare Conference Call TranscriptN/A
2022-09-08 10:35 ESTNewsEditas Medicine, Inc. (EDIT) Presents at 2022 Wells Fargo Healthcare Conference (Transcript)N/A
2022-08-25 11:55 ESTNewsEditas Medicine: Management Upbeat After Lifting Of Clinical HoldN/A
2022-08-24 03:30 ESTNewsEditas: End Of Year Data Readouts For SCD And Rare Eye Disease StudiesN/A
2022-08-04 10:30 ESTNewsEditas Medicine, Inc. (EDIT) CEO Gilmore O'Neill on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 20:10 ESTNewsEditas Medicine GAAP EPS of -$0.78 beats by $0.06, revenue of $6.36M beats by $2.07MN/A
2022-08-03 20:10 ESTNewsEditas Medicine up 13% following Q2 2022 top and bottom line beats as net loss narrowsN/A
2022-08-03 20:09 ESTNewsGene editing companies benefitting from Roche deal with CAR-T player Poseida TherapeuticsN/A
2022-08-02 14:41 ESTNewsEditas Medicine Q2 2022 Earnings PreviewN/A
2022-07-18 11:17 ESTNewsBaisong Mei joins Editas Medicine as Chief Medical OfficerN/A
2022-06-07 11:20 ESTNewsEditas in licensing deal with Immatics for cancer therapiesN/A
2022-06-06 20:01 ESTNewsEditas: Tackling Rare Eye Disease With Use Of Crispr TechnologyN/A
2022-05-13 12:13 ESTNewsEditas Medicine granted Orphan Drug Designation for beta thalassemia candidateN/A
2022-05-05 02:50 ESTNewsEditas Medicine GAAP EPS of -$0.74 beats by $0.07, revenue of $6.77M beats by $2.92MN/A
2022-05-05 02:50 ESTNewsEditas Medicine, Inc. (EDIT) CEO Jim Mullen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 06:05 ESTNewsEditas Medicine Q1 2022 Earnings PreviewN/A
2022-04-26 11:41 ESTNewsEditas gets FDA rare pediatric disease status for gene-edited drug EDIT-301 for beta thalassemiaN/A

About Editas Medicine, Inc (EDIT):

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis type 10, a genetic form of vision loss that leads to blindness in childhood. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa 4, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumors; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has a early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited to discover, develop, and commercialize new gene editing medicines for a range of ocular disorders; and research collaboration with Asklepios BioPharmaceutical, Inc. to develop a therapy to treat a neurological disease, as well as research collaboration with AskBio and collaboration with m BlueRock Therapeutics LP. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

EDIT Quotes by TradingView

See Advanced Chart

General

  • Name Editas Medicine, Inc
  • Symbol EDIT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 235
  • Fiscal Year EndDecember
  • IPO Date2016-02-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.editasmedicine.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 26.85
  • Price/Book (Most Recent Quarter) 6.25
  • Enterprise Value Revenue 25.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.34
  • Next Year EPS Estimate -$3.49
  • Next Quarter EPS Estimate -$0.78
  • Profit Margin -128%
  • Operating Margin -149%
  • Return on Assets -16%
  • Return on Equity -35%
  • Revenue 90.73 million
  • Earnings Per Share -$2.14
  • Revenue Per Share $1.55
  • Gross Profit -67264000
  • Quarterly Earnings Growth -7%
View More

Highlights

  • Market Capitalization 2.91 billion
  • EBITDA -106383000
  • PE Ratio -1.59
  • Analyst Target Price $52.83
  • Book Value Per Share $6.29
View More

Share Statistics

  • Shares Outstanding 67.36 million
  • Shares Float 66.37 million
  • % Held by Insiders 137%
  • % Held by Institutions 82.21%
  • Shares Short 11.31 million
  • Shares Short Prior Month 9.84 million
  • Short Ratio 4.22
  • Short % of Float 17%
  • Short % of Shares Outstanding 17%
View More

Technicals

  • Beta 2.08
  • 52 Week High $99.95
  • 52 Week Low $18.2
  • 50 Day Moving Average 52.94
  • 200 Day Moving Average 46.49
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Editas Medicine, Inc (EDIT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Editas Medicine, Inc (EDIT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$1.00-$0.88-13.56%
2020-09-302020-11-05$N/A$0.12-$0.63119.14%
2020-06-302020-08-06$N/A-$0.43-$0.8247.37%
2020-03-312020-05-07$N/A-$0.69-$0.8114.81%
2019-12-312020-02-26$12.28 million-$0.74$0.06-1380.28%
2019-09-302019-11-12$3.85 million-$0.66-$0.739.3%
2019-06-302019-08-06$2.33 million-$0.69-$0.62-10.79%
2019-03-312019-05-07$2.07 million-$0.60-$0.645.78%
2018-12-312019-02-28$6.12 million-$0.52-$0.555.45%
2018-09-302018-11-07$14.52 million-$0.32-$0.8160.7%
2018-06-302018-08-06$7.37 million-$0.82-$0.66-25.1%
2018-03-312018-05-03$3.93 million-$0.67-$0.8016.47%
2017-12-312018-03-06$3.67 million-$0.84-$0.67-25.88%
2017-09-302017-11-07$6.28 million-$0.64-$0.63-1.81%
2017-06-302017-08-09$3.1 million-$0.65-$0.57-13.38%
2017-03-312017-05-15$682000-$0.85-$0.77-11.05%
2016-12-312017-03-03$898000-$1.10-$0.65-68.69%
2016-09-302016-11-07$962000-$0.59-$0.648%
2016-06-302016-08-09$3.39 million-$0.54-$0.562.76%
2016-03-312016-05-13$805000-$0.80-$0.32-150.94%
2015-12-312016-03-30$792000-$4.05-$8.5652.69%

Editas Medicine, Inc (EDIT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Editas Medicine, Inc (EDIT) Chart:

Editas Medicine, Inc (EDIT) News:

Below you will find a list of latest news for Editas Medicine, Inc (EDIT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Editas Medicine, Inc (EDIT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-03-210.51.63CALL26 33437.42TRUE-0.65-0.29
2025-03-2111.4CALL2 73358.6TRUE-0.75-0.35
2025-03-211.50.69CALL359 608170.21TRUE-1.01-0.59
2025-03-2120.4CALL482 723161.84TRUE-0.9-0.69
2025-03-212.50.3CALL1517 2435192.64FALSE-0.75-0.71
2025-03-2150.08CALL1230 939230.21FALSE-0.32-0.8
2025-03-217.50.05CALL14 53267.3FALSE-0.2-0.8
2025-03-210.50PUT0 0332.79FALSE00
2025-03-2110.04PUT10 77204.72FALSE-0.01-0.2
2025-03-211.50.09PUT242 493146.66FALSE0.040.8
2025-03-2120.35PUT213 253169.24FALSE0.150.75
2025-03-212.50.72PUT301 257187.24TRUE0.340.89
2025-03-2152.63PUT5 4201.35TRUE0.380.17
2025-03-217.50PUT0 0506.13TRUE00
2025-04-170.52.25CALL10 0950.95TRUE2.250
2025-04-1710CALL0 0222.98TRUE00
2025-04-171.51.15CALL50 0323.83TRUE1.150
2025-04-1720CALL0 0131.87TRUE00
2025-04-172.50.45CALL24 0184.62FALSE0.450
2025-04-1750.15CALL8 0197.51FALSE0.150
2025-04-177.50CALL0 0247.14FALSE00
2025-04-170.50PUT0 0425.33FALSE00
2025-04-1710PUT0 0234.31FALSE00
2025-04-171.50PUT0 0189.59FALSE00
2025-04-1720.4PUT10 0139.2FALSE0.40
2025-04-172.50PUT0 0145.61TRUE00
2025-04-1750PUT0 0210.88TRUE00
2025-04-177.50PUT0 0216.55TRUE00
2025-05-160.51.6CALL0 17330.46TRUE00
2025-05-1612.11CALL0 716149.47TRUE00
2025-05-161.50.75CALL177 1002119.31TRUE-1.05-0.58
2025-05-1620.65CALL2712 2864160.57TRUE-0.85-0.57
2025-05-162.50.42CALL354 2511141.67FALSE-0.77-0.65
2025-05-1650.18CALL543 2138169.64FALSE-0.42-0.7
2025-05-167.50.1CALL13 718180.73FALSE-0.25-0.71
2025-05-160.50.05PUT0 1195.21FALSE00
2025-05-1610.05PUT0 28128.43FALSE00
2025-05-161.50.22PUT5 76135.29FALSE0.070.47
2025-05-1620.4PUT3 99113.9FALSE0.050.14
2025-05-162.50.8PUT22 363132.07TRUE0.20.33
2025-05-1652.48PUT0 369148.55TRUE00
2025-05-167.54.7PUT0 0181.06TRUE00
2025-08-150.52.15CALL15 15227.54TRUE0.250.13
2025-08-1511.37CALL51 28070.66TRUE-0.83-0.38
2025-08-151.50.99CALL103 197140.05TRUE-0.96-0.49
2025-08-1520.76CALL30 97131.7TRUE-0.74-0.49
2025-08-152.50.6CALL60 906129.23FALSE-0.55-0.48
2025-08-1550.32CALL29 513144.97FALSE-0.43-0.57
2025-08-157.50.49CALL0 277251.96FALSE00
2025-08-150.50PUT0 0298.28FALSE00
2025-08-1510.12PUT10 54122.05FALSE0.020.2
2025-08-151.50.33PUT0 790.5FALSE00
2025-08-1520.5PUT1 128119.25FALSE-0.04-0.07
2025-08-152.51.25PUT0 1121TRUE00
2025-08-1553.8PUT0 0137.38TRUE00
2025-08-157.50PUT0 0135.29TRUE00
2026-01-160.51.9CALL1 49284.71TRUE-0.8-0.3
2026-01-1611.45CALL140 432155.92TRUE-0.82-0.36
2026-01-161.50.9CALL34 498111.17TRUE-0.95-0.51
2026-01-1620.85CALL77 1101107.78TRUE-0.95-0.53
2026-01-162.50.75CALL398 3552113.11FALSE-0.92-0.55
2026-01-1650.45CALL112 4606122FALSE-0.49-0.52
2026-01-167.50.35CALL97 1420131FALSE-0.34-0.49
2026-01-16100.29CALL96 1890136.61FALSE-0.41-0.59
2026-01-1612.50.3CALL14 416148.38FALSE-0.15-0.33
2026-01-16150.55CALL0 670152.64FALSE00
2026-01-1617.50.2CALL13 335146.79FALSE-0.3-0.6
2026-01-16200.2CALL15 1111152.22FALSE-0.2-0.5
2026-01-160.50.06PUT0 20FALSE00
2026-01-1610.14PUT105 2596.6FALSE0.040.4
2026-01-161.50.38PUT16 55100.65FALSE00
2026-01-1620.62PUT1 29108.14FALSE0.120.24
2026-01-162.51.05PUT25 603104.96TRUE0.250.31
2026-01-1652.75PUT1 153120.53TRUE2.750
2026-01-167.55.28PUT14 99134.13TRUE5.280
2026-01-16108.7PUT0 9126.45TRUE00
2026-01-1612.58.83PUT0 0140.83TRUE00
2026-01-16156.8PUT0 0202.49TRUE00
2026-01-1617.58.6PUT0 0198.79TRUE00
2026-01-162018.64PUT0 0222.91TRUE00

Latest EDIT Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST6$9.99
Jun 13, 2022 7:59 PM EST1$9.99
Jun 13, 2022 7:59 PM EST1$9.99
Jun 13, 2022 7:59 PM EST4$9.99
Jun 13, 2022 7:59 PM EST7$9.99

Editas Medicine, Inc (EDIT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000110465920076658/0001104659-20-076658-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000009375119000066/0000093751-19-000066-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000021545719004070/0000215457-19-004070-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000031506618002155/0000315066-18-002155-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000083423720005329/0000834237-20-005329-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000093247119004821/0000932471-19-004821-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000093247119004830/0000932471-19-004830-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000095010320002668/0000950103-20-002668-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1650664/000104746919002633/0001047469-19-002633-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1650664/000104746920002641/0001047469-20-002641-index.htm
2020-05-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1650664/000104746920003096/0001047469-20-003096-index.htm
2020-06-23S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1650664/000104746920003806/0001047469-20-003806-index.htm
2020-06-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1650664/000104746920003852/0001047469-20-003852-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1650664/000110465919024075/0001104659-19-024075-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000110465920018014/0001104659-20-018014-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000110465920021157/0001104659-20-021157-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1650664/000110465920052376/0001104659-20-052376-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000110465920076658/0001104659-20-076658-index.htm
2020-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000110465920113794/0001104659-20-113794-index.htm
2019-10-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000114036119018224/0001140361-19-018224-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000114036120002957/0001140361-20-002957-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000114420419007778/0001144204-19-007778-index.htm
2018-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm
2018-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm
2018-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm
2018-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm
2018-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm
2018-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm
2018-11-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm
2018-12-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013607/0001179110-18-013607-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018013609/0001179110-18-013609-index.htm
2018-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019000574/0001179110-19-000574-index.htm
2019-01-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019000576/0001179110-19-000576-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019000653/0001179110-19-000653-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001235/0001179110-19-001235-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001237/0001179110-19-001237-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001239/0001179110-19-001239-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001511/0001179110-19-001511-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001519/0001179110-19-001519-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001682/0001179110-19-001682-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019001684/0001179110-19-001684-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019003510/0001179110-19-003510-index.htm
2019-03-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019003602/0001179110-19-003602-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007669/0001179110-19-007669-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007675/0001179110-19-007675-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007680/0001179110-19-007680-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007682/0001179110-19-007682-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019007685/0001179110-19-007685-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019009249/0001179110-19-009249-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019010316/0001179110-19-010316-index.htm
2019-10-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019011287/0001179110-19-011287-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911019011289/0001179110-19-011289-index.htm
2020-01-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020000466/0001179110-20-000466-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020000468/0001179110-20-000468-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020001362/0001179110-20-001362-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020005605/0001179110-20-005605-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007263/0001179110-20-007263-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007265/0001179110-20-007265-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007273/0001179110-20-007273-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007277/0001179110-20-007277-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020007280/0001179110-20-007280-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020008367/0001179110-20-008367-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020009219/0001179110-20-009219-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000117911020010507/0001179110-20-010507-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm
2019-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1650664/000121465919006312/0001214659-19-006312-index.htm
2018-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837018006448/0001558370-18-006448-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837018006577/0001558370-18-006577-index.htm
2018-10-2310-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837018007793/0001558370-18-007793-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837018008795/0001558370-18-008795-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837018008907/0001558370-18-008907-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837018009647/0001558370-18-009647-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837018009781/0001558370-18-009781-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019000186/0001558370-19-000186-index.htm
2019-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019000455/0001558370-19-000455-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019001317/0001558370-19-001317-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1650664/000155837019001364/0001558370-19-001364-index.htm
2019-03-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1650664/000155837019002001/0001558370-19-002001-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019004256/0001558370-19-004256-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837019004444/0001558370-19-004444-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019005722/0001558370-19-005722-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019007255/0001558370-19-007255-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837019007470/0001558370-19-007470-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019008737/0001558370-19-008737-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837019010674/0001558370-19-010674-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837019010798/0001558370-19-010798-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020000118/0001558370-20-000118-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020001469/0001558370-20-001469-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1650664/000155837020001476/0001558370-20-001476-index.htm
2020-02-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1650664/000155837020001479/0001558370-20-001479-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020005306/0001558370-20-005306-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020005548/0001558370-20-005548-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837020005883/0001558370-20-005883-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020006724/0001558370-20-006724-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020007536/0001558370-20-007536-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020009648/0001558370-20-009648-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837020009821/0001558370-20-009821-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1650664/000155837020012865/0001558370-20-012865-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1650664/000155837020013022/0001558370-20-013022-index.htm
2018-10-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999718008672/9999999997-18-008672-index.htm
2018-10-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999718008675/9999999997-18-008675-index.htm
2018-10-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999718008677/9999999997-18-008677-index.htm
2018-10-25CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999718008797/9999999997-18-008797-index.htm
2019-09-23SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1650664/999999999719007052/9999999997-19-007052-index.htm
2019-09-26SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1650664/999999999719007131/9999999997-19-007131-index.htm
2019-10-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999719007341/9999999997-19-007341-index.htm
2019-12-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999719007956/9999999997-19-007956-index.htm
2020-04-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1650664/999999999720002192/9999999997-20-002192-index.htm

Editas Medicine, Inc (EDIT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Editas Medicine, Inc (EDIT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 137%
Institutional Ownership: 8221%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-08-31Andrew A. F. HackChief Financial OfficerSell10,000.0032.23322,300.000.00https://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm
2018-09-28Andrew A. F. HackChief Financial OfficerSell8,000.0032.08256,640.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm
2018-10-26Andrew A. F. HackChief Financial OfficerSell6,000.0025.70154,200.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm
2018-11-23Andrew A. F. HackChief Financial OfficerSell100.0028.612,861.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm
2019-01-04Andrew A. F. HackChief Financial OfficerSell7,000.0022.48157,360.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm
2019-02-04Andrew A. F. HackChief Financial OfficerSell6,895.0021.39147,484.050.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm
2018-06-18Vickesh MyerChief Technology OfficerSell4,300.0037.75162,325.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-06-18Vickesh MyerChief Technology OfficerSell2,700.0038.71104,517.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-06-19Vickesh MyerChief Technology OfficerSell7,000.0038.39268,730.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-07-17Vickesh MyerChief Technology OfficerSell3,000.0034.66103,980.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-07-17Vickesh MyerChief Technology OfficerSell4,000.0036.50146,000.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-07-18Vickesh MyerChief Technology OfficerSell6,150.0035.46218,079.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-07-18Vickesh MyerChief Technology OfficerSell850.0036.2530,812.500.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-08-17Vickesh MyerChief Technology OfficerSell3,000.0029.6588,950.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-08-20Vickesh MyerChief Technology OfficerSell3,600.0029.81107,316.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-08-20Vickesh MyerChief Technology OfficerSell400.0030.4112,164.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-09-17Vickesh MyerChief Technology OfficerSell3,000.0032.3396,990.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-09-18Vickesh MyerChief Technology OfficerSell4,000.0032.19128,760.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-10-17Vickesh MyerChief Technology OfficerSell3,000.0028.8786,610.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-10-18Vickesh MyerChief Technology OfficerSell4,000.0029.44117,760.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-11-19Vickesh MyerChief Technology OfficerSell2,700.0028.1275,924.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-11-19Vickesh MyerChief Technology OfficerSell300.0028.858,655.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-11-20Vickesh MyerChief Technology OfficerSell4,000.0026.50106,000.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-12-17Vickesh MyerChief Technology OfficerSell700.0028.3419,838.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2018-12-18Vickesh MyerChief Technology OfficerSell4,000.0027.41109,640.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-17Vickesh MyerChief Technology OfficerSell3,000.0026.1878,540.000.00https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2019-01-18Vickesh MyerChief Technology OfficerSell4,000.0026.50106,000.000.00https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2019-02-20Vickesh MyerChief Technology OfficerSell3,000.0020.4261,260.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm
2019-03-18Vickesh MyerChief Technology OfficerSell3,000.0024.5073,500.000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm
2018-11-23Andrew A. F. HackChief Financial OfficerSell5,184.0028.14145,877.76100.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm
2018-08-31Andrew A. F. HackChief Financial OfficerBuy10,000.006.4864,800.0010,000.00https://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm
2019-08-19Cynthia CollinsCEOSell5,193.0025.83134,135.1911,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm
2019-01-08Katrine BosleyPresident and CEOSell12,000.0025.27303,240.001,204,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019000653/0001179110-19-000653-index.htm
2018-12-03Katrine BosleyPresident and CEOSell100.0032.393,239.001,216,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm
2018-12-03Katrine BosleyPresident and CEOSell11,900.0031.92379,848.001,217,066.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm
2018-11-01Katrine BosleyPresident and CEOSell8,600.0027.21234,006.001,228,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm
2018-11-01Katrine BosleyPresident and CEOSell3,400.0026.0388,502.001,237,566.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm
2018-10-01Katrine BosleyPresident and CEOSell5,766.0031.44181,283.041,240,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm
2018-10-01Katrine BosleyPresident and CEOSell6,234.0030.64191,009.761,246,732.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm
2018-09-04Katrine BosleyPresident and CEOSell1,213.0033.0740,113.911,252,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm
2018-09-04Katrine BosleyPresident and CEOSell10,787.0032.27348,096.491,254,179.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm
2018-08-20Katrine BosleyPresident and CEOSell5,433.0030.43165,326.191,264,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm
2018-08-20Katrine BosleyPresident and CEOSell6,567.0029.95196,681.651,270,399.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm
2018-08-01Katrine BosleyPresident and CEOSell2,100.0030.1263,252.001,276,966.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm
2018-08-01Katrine BosleyPresident and CEOSell6,233.0029.36183,000.881,279,066.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm
2018-07-02Katrine BosleyPresident and CEOSell5,333.0036.46194,441.181,285,299.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm
2018-07-02Katrine BosleyPresident and CEOSell3,000.0036.00108,000.001,290,632.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm
2019-08-06Cynthia CollinsCEOBuy8,283.0016,566.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019009249/0001179110-19-009249-index.htm
2019-08-19Cynthia CollinsCEOBuy8,283.0016,566.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm
2019-03-05Jessica HopfieldDirectorBuy10,200.0023.94244,188.0016,900.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019003510/0001179110-19-003510-index.htm
2020-01-09MICHELLE ROBERTSONChief Financial OfficerBuy20,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020000468/0001179110-20-000468-index.htm
2020-02-03Charles AlbrightChief Scientific OfficerSell5,549.0026.54147,287.6620,553.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm
2019-10-28Judith R AbramsChief Medical OfficerBuy25,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019011289/0001179110-19-011289-index.htm
2020-10-15Charles AlbrightEVP/Chief Scientific OfficerSell3,000.0031.3994,170.0025,135.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020010507/0001179110-20-010507-index.htm
2020-01-31Charles AlbrightChief Scientific OfficerBuy17,977.0026,102.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm
2018-06-18Vickesh MyerChief Technology OfficerBuy2,700.000.651,755.002,700.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-11-19Vickesh MyerChief Technology OfficerBuy2,700.000.651,755.002,700.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2020-08-07Charles AlbrightEVP/Chief Scientific OfficerSell238.0034.998,327.6228,135.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm
2020-08-17Charles AlbrightEVP/Chief Scientific OfficerSell10,000.0035.29352,900.0028,135.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm
2020-07-15Charles AlbrightEVP/Chief Scientific OfficerSell3,000.0032.2296,660.0028,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020008367/0001179110-20-008367-index.htm
2020-08-06Charles AlbrightEVP/Chief Scientific OfficerSell10,000.0037.47374,700.0028,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm
2018-11-19Vickesh MyerChief Technology OfficerBuy300.000.65195.00300.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-07-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-08-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-09-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-10-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-12-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-17Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2019-02-20Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm
2019-03-18Vickesh MyerChief Technology OfficerBuy3,000.000.651,950.003,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm
2020-05-06Charles AlbrightEVP/Chief Scientific OfficerSell151.0025.283,817.2831,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020005605/0001179110-20-005605-index.htm
2019-09-11Cynthia CollinsCEOBuy20,000.0031,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019010316/0001179110-19-010316-index.htm
2020-02-07Charles AlbrightChief Scientific OfficerSell622.0026.9516,762.9031,524.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm
2020-02-06Charles AlbrightChief Scientific OfficerBuy11,593.0032,146.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm
2018-08-20Vickesh MyerChief Technology OfficerBuy3,600.0011.2140,356.003,600.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2020-08-17Charles AlbrightEVP/Chief Scientific OfficerBuy10,000.0016.51165,100.0038,135.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm
2020-08-06Charles AlbrightEVP/Chief Scientific OfficerBuy10,000.0016.51165,100.0038,373.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm
2018-08-20Vickesh MyerChief Technology OfficerBuy400.0011.214,484.00400.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm
2018-07-17Vickesh MyerChief Technology OfficerBuy4,000.000.652,600.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2018-09-18Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm
2018-10-18Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm
2018-11-20Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm
2018-12-18Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-18Vickesh MyerChief Technology OfficerBuy4,000.0011.2144,840.004,000.00https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm
2018-06-18Vickesh MyerChief Technology OfficerBuy4,300.000.652,795.004,300.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2020-08-20Cynthia CollinsCEOSell1,976.0036.6672,440.1645,022.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020009219/0001179110-20-009219-index.htm
2020-02-06Cynthia CollinsCEOBuy15,625.0046,998.00https://www.sec.gov/Archives/edgar/data/1650664/000117911020001362/0001179110-20-001362-index.htm
2018-11-23Andrew A. F. HackChief Financial OfficerBuy5,284.006.4834,240.325,284.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm
2018-10-26Andrew A. F. HackChief Financial OfficerBuy6,000.006.4838,880.006,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm
2018-07-18Vickesh MyerChief Technology OfficerBuy6,150.0011.2168,941.506,150.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm
2019-02-04Andrew A. F. HackChief Financial OfficerBuy6,895.006.4844,679.606,895.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm
2018-12-17Vickesh MyerChief Technology OfficerSell2,300.0027.7563,825.00700.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm
2019-01-04Andrew A. F. HackChief Financial OfficerBuy7,000.006.4845,360.007,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm
2018-06-19Vickesh MyerChief Technology OfficerBuy7,000.0011.2178,470.007,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm
2018-09-28Andrew A. F. HackChief Financial OfficerBuy8,000.006.4851,840.008,000.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm
2018-07-18Vickesh MyerChief Technology OfficerBuy850.0011.219,528.50850.00https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm